Viewing Study NCT06010667

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-01-01 @ 8:09 PM
Study NCT ID: NCT06010667
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-24
First Post: 2023-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
Keywords: